Analyst firm Leerink partners raised the price target for Roivant based on share count forecast on August 13, 2025.
Steady: 0 in the last 7 days
Updated sep 22
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst firm Leerink partners raised the price target for Roivant based on share count forecast on August 13, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Acton's political rivals are contrasting her wealth sources, which stem from a company she founded that is generating wealth.Sub-event
Leerink partners set market benchmarks for drug trials related to Roivant Sciences.1 source
Fifth Third Bancorp increased its stake in Roivant Sciences, and Leerink Partners issued a new price target.1 source
Leerink partners raised price target for Roivant.1 source
Keep exploring
The entities involved
-
Roivant Sciences (United States)
company in New York, United States
-
Leerink partners
U.S. investment bank
Related events
Coverage
Newest first; wire copies grouped- yahoo.com
- themarketsdaily.com
- Motley FoolWhy Roivant Sciences Stock Bounced Back on Tuesday A day after it published its latest set of quarterly earnings, an analyst bumped his price target higher. He also maintained his equivalent of a buy